https://www.selleckchem.com/products/mrt68921.html
48±4.7) to (12.01±5.8) (P=.002). However, no significant difference was observed in serum lipid level in the study groups before and after the intervention (all P.05). Flaxseed consumption may improve adiposity markers, such as adiponectin level. Thus, flaxseed consumption could be an adjunctive therapy to attenuate central obesity. Serum lipid profile has not changed meaningfully after flaxseed consumption. Flaxseed consumption may improve adiposity markers, such as adiponectin level. Thus, flaxseed consumption could be an adjunct